Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ALBBY US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

ALBBY US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Alibaba Health Information Technology Limited/ADR Unsponsored ADR(ALBBY US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Alibaba Health Information Technology Limited/ADR Unsponsored ADR(ALBBY US)

Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
$7.75+0.263.45%(Market Open · 21:00:00 UTC)

Financials & Metrics

FinancialsChartingShort InterestEmployees
$7.75+0.263.45%(Market Open · 21:00:00 UTC)

Alibaba Health Information Technology Limited/ADR Unsponsored ADR — Company Profile

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Exchange
UU
CEO
Yong Yu
Headquarters
Hong Kong, NY, HK
IPO Date
Sep 30, 2019
Employees
1,394
Website
www.alihealth.cn

Key Metrics

Price
$7.05
Market Cap
$5.68B
Revenue (TTM)
$33.19B
Net Income (TTM)
$1.88B
EPS (TTM)
2.40
P/E (TTM)
0.00
P/B (TTM)
0.32
Dividend Yield
0.00%
ROE (TTM)
7.13%
ROA (TTM)
5.39%
Operating Margin
6.71%
Beta
0.64

Dividends

Alibaba Health Information Technology Limited/ADR Unsponsored ADR — Company Profile

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Exchange
UU
CEO
Yong Yu
Headquarters
Hong Kong, NY, HK
IPO Date
Sep 30, 2019
Employees
1,394
Website
www.alihealth.cn

Key Metrics

Price
$7.05
Market Cap
$5.68B
Revenue (TTM)
$33.19B
Net Income (TTM)
$1.88B
EPS (TTM)
2.40
P/E (TTM)
0.00
P/B (TTM)
0.32
Dividend Yield
0.00%
ROE (TTM)
7.13%
ROA (TTM)
5.39%
Operating Margin
6.71%
Beta
0.64

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Website
www.alihealth.cn
Location
Hong Kong, NY, HK
Phone852 2583 9333
Employees1,394
CEOYong Yu
IPO DateSep 30, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(4)

Expand
  • F-6EFEffective registration statement (depository shares)16 Jun 2023
  • F-6EFEffective registration statement (depository shares)2 May 2023
  • F-6EFEffective registration statement (depository shares)20 Sep 2021
  • F-6EFUNSPONSORED FORM F-612 Jun 2017

Mentions in Filings

  • *Shunyan Zhu* has served as our independent director since January 2025. Mr. Zhu has served as an executive director and the chairman of the board of directors of <strong>Alibaba Health Information Technology</strong> Ltd. (SEHK: 00241, “Alibaba Health”) from March 2020, and he currently serves as the chairman of the nomination committee of the board of directors of Alibaba Health. From March 2020 to November 2023, he served as the chief executive officer of Alib …
    Here Group LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·20-F - ANNUAL REPORT FY 2026·FY26·30 Oct
  • … nuary 2020. Prior to joining us, Mr. Li served as the chief financial officer of Sunlands Technology Group (NYSE: STG) from September 2017 to April 2020. Mr. Li served as the chief financial officer of <strong>Alibaba Health Information Technology Limited</strong> (HKEx: 241), a subsidiary of Alibaba Group, from September 2015 to September 2017. Prior to that, he was the chief financial officer at Jiuxian.com, a leading online platform for alcohol offerings from …
    Cloopen Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99 - SC 13E3/A - Going private transaction statement (amendment)·Q3 26·21 Aug
  • … s Announcements**”) in relation to our offering of HK$ 12.023 billion aggregate principal amount of zero coupon exchangeable bonds due 2032 (the “**2025 Bonds**”) by reference to the ordinary shares of <strong>Alibaba Health Information Technology Limited</strong> (“**Alibaba Health**”) that are listed on the Hong Kong Stock Exchange (HKEX: 0241) (“**AH Shares**”). Unless otherwise defined, all capitalized terms used in this announcement shall have the same meani …
    Alibaba Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99.1 - 6-K - EXHIBIT 99.1·14 Aug·14 Aug
  • #\*Alibaba Health Information Technology, Ltd. 2,240,000 1,870,085 Ω#A-Living Smart City Services Co., Ltd., Class H 666,750 199,776 All Winner Technology Co., Ltd., Class A 31,290 207,286 Allmed Medical Products Co., Ltd., Class A 72,300 120,235 \*Alpha Group, Class A 67,800 91,391 Ω\*Alphamab Oncology 135,000 154,020 Aluminum Corp. of China, Ltd., Class H 3,466,000 6,146,728 \*Amlogic Shang …
    Dimensional ETF TrustAlibaba Health Information Technology Limited/ADR Unsponsored ADR·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … nuary 2020. Prior to joining us, Mr. Li served as the chief financial officer of Sunlands Technology Group (NYSE: STG) from September 2017 to April 2020. Mr. Li served as the chief financial officer of <strong>Alibaba Health Information Technology Limited</strong> (HKEx: 241), a subsidiary of Alibaba Group, from September 2015 to September 2017. Prior to that, he was the chief financial officer at Jiuxian.com, a leading online platform for alcohol offerings from …
    Cloopen Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99 - SC 13E3/A - Going private transaction statement (amendment)·Q3 26·11 Aug
  • … Limited since May 2023, an independent non-executive director of Trip.com (NASDAQ: TCOM: HKEX: 9961) since February 2026, an independent non-executive director and chairwoman of the audit committee of <strong>Alibaba Health Information Technology Limited</strong> (HKEX: 00241) since August 2023 and an independent non-executive director and chairwoman of the audit committee of Swire Properties Limited (HKEX: 01972) since May 2017. Ms. Wu has also served as an ind …
    MakeMyTrip LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99.4 - 6-K - Current report (foreign private issuer)·Q2 27·7 Aug

Key Stats

Trading

Px/Chg 1D$7.05 / -9.38%
Avg Volume527.77
Beta0.64
Mkt Cap5.68B
FD Mkt Cap6.48B

Float

Shrs Out/Float806.32M / 293.23M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV13.85M
EV/EBITDA0.00
EV/Sales0.00
P/B0.32
P/S0.00
FCF Yield13.36%
ROE7.13%
ROA5.39%
Current Ratio2.71

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgSep '22Sep '23Sep '24Sep '25Oct '26
PRICE-BASED RATIOS
Price / Earnings6.56-23.4815.678.2723.708.65
Price / Sales0.440.300.310.270.960.33
Price / Book Value0.560.440.550.500.960.32
Price / Free Cash Flow16.4815.2333.566.9119.247.48
ENTERPRISE VALUE METRICS
Enterprise Value2,149.8-4,203.8-2,473.63,871.513,541.313.8
Enterprise Value / Sales0.14-0.20-0.090.140.830.00
Enterprise Value / EBITDA29.3322.35101.063.8819.340.02
Enterprise Value / EBIT17.7816.9048.034.1019.880.02

Financials

Full Financials
Millions CNY5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue12.7%20,577.626,763.027,026.630,598.333,191.5
Gross Income18%4,108.05,701.35,895.37,432.17,955.2
EBITDA—-188.1-24.5999.11,620.21,829.8
EBIT—-248.7-51.5945.41,562.61,778.2
Net Income—-265.6535.7883.51,432.41,876.0
EPS (Diluted)—-0.390.791.251.782.40
BALANCE SHEET
Cash & ST Inv-24.5%10,547.910,917.29,553.18,099.810,445.1
Total Assets4.6%19,202.020,747.619,705.321,178.423,006.9
Total Liabilities42.3%5,129.75,600.25,187.74,865.35,217.0
Total Shareholder Equity6%14,098.415,173.714,544.216,312.217,788.7
CASH FLOW
Net Operating Cash Flow48.7%424.4255.71,079.81,395.0—
Cap Ex8.2%-14.9-5.6-22.8-18.9—
Free Cash Flow49.8%409.4250.11,057.11,376.1—

Enterprise Value Bridge

Millions CNY23 Oct '26
Price (As of 23 Oct '26)6.78
Basic Shares806.32
Market Cap5,466.9
Diluted Shares809.95
Fully Diluted Shares Outstanding809.95
Fully Diluted Market Cap5,491.4
+Consolidated Debt59.5
−In-the-Money Convertible Debt—
+Capital Leases30.1
+Operating Leases—
−Cash & Equivalents-5,731.4
−Short-term Investments-4,713.7
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest1.2
+Pension Liabilities—
Enterprise Value-203.9

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US

Last Dividend
$0.00
Last Yield
0.00%

Summary

Alibaba Health Information Technology Limited, an investment holding entity based in Causeway Bay, Hong Kong, manages a diverse range of operations across Mainland China and Hong Kong. Its core business revolves around pharmaceutical retail, operating an extensive e-commerce platform for health-related goods, and delivering a broad spectrum of digital healthcare services. The company directly sells a wide array of health products, including prescription and over-the-counter medications, nutritional supplements, various medical devices, and contact lenses. These are distributed to both individual consumers (B2C) and businesses (B2B) through its online storefronts on Tmall.com and a network of physical pharmacy outlets. Its e-commerce platform further offers pharmaceutical products, medical equipment, health foods, sexual health and family planning items, alongside integrated medical and healthcare services. Beyond product sales, Alibaba Health provides comprehensive medical and wellness services such as health checkups, nucleic acid testing, online consultations, appointment booking, vaccination programs, and Traditional Chinese Medicine therapies. These services are conveniently accessible via popular platforms like Taobao, Tmall, Alipay, the Dr. Deer APP, Gaode, DingTalk, and Quark. The company also engages in supply chain tracking, the provision of network hospital services, internet-based healthcare information, and technical support. Additionally, it operates internet hospitals and offers asset management services. Notably, the firm adopted its current name, Alibaba Health Information Technology Limited, in September 2014, having previously been known as CITIC 21CN Company Limited.

Website
www.alihealth.cn
Location
Hong Kong, NY, HK
Phone852 2583 9333
Employees1,394
CEOYong Yu
IPO DateSep 30, 2019

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(4)

Expand
  • F-6EFEffective registration statement (depository shares)16 Jun 2023
  • F-6EFEffective registration statement (depository shares)2 May 2023
  • F-6EFEffective registration statement (depository shares)20 Sep 2021
  • F-6EFUNSPONSORED FORM F-612 Jun 2017

Mentions in Filings

  • *Shunyan Zhu* has served as our independent director since January 2025. Mr. Zhu has served as an executive director and the chairman of the board of directors of <strong>Alibaba Health Information Technology</strong> Ltd. (SEHK: 00241, “Alibaba Health”) from March 2020, and he currently serves as the chairman of the nomination committee of the board of directors of Alibaba Health. From March 2020 to November 2023, he served as the chief executive officer of Alib …
    Here Group LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·20-F - ANNUAL REPORT FY 2026·FY26·30 Oct
  • … nuary 2020. Prior to joining us, Mr. Li served as the chief financial officer of Sunlands Technology Group (NYSE: STG) from September 2017 to April 2020. Mr. Li served as the chief financial officer of <strong>Alibaba Health Information Technology Limited</strong> (HKEx: 241), a subsidiary of Alibaba Group, from September 2015 to September 2017. Prior to that, he was the chief financial officer at Jiuxian.com, a leading online platform for alcohol offerings from …
    Cloopen Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99 - SC 13E3/A - Going private transaction statement (amendment)·Q3 26·21 Aug
  • … s Announcements**”) in relation to our offering of HK$ 12.023 billion aggregate principal amount of zero coupon exchangeable bonds due 2032 (the “**2025 Bonds**”) by reference to the ordinary shares of <strong>Alibaba Health Information Technology Limited</strong> (“**Alibaba Health**”) that are listed on the Hong Kong Stock Exchange (HKEX: 0241) (“**AH Shares**”). Unless otherwise defined, all capitalized terms used in this announcement shall have the same meani …
    Alibaba Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99.1 - 6-K - EXHIBIT 99.1·14 Aug·14 Aug
  • #\*Alibaba Health Information Technology, Ltd. 2,240,000 1,870,085 Ω#A-Living Smart City Services Co., Ltd., Class H 666,750 199,776 All Winner Technology Co., Ltd., Class A 31,290 207,286 Allmed Medical Products Co., Ltd., Class A 72,300 120,235 \*Alpha Group, Class A 67,800 91,391 Ω\*Alphamab Oncology 135,000 154,020 Aluminum Corp. of China, Ltd., Class H 3,466,000 6,146,728 \*Amlogic Shang …
    Dimensional ETF TrustAlibaba Health Information Technology Limited/ADR Unsponsored ADR·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … nuary 2020. Prior to joining us, Mr. Li served as the chief financial officer of Sunlands Technology Group (NYSE: STG) from September 2017 to April 2020. Mr. Li served as the chief financial officer of <strong>Alibaba Health Information Technology Limited</strong> (HKEx: 241), a subsidiary of Alibaba Group, from September 2015 to September 2017. Prior to that, he was the chief financial officer at Jiuxian.com, a leading online platform for alcohol offerings from …
    Cloopen Group Holding LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99 - SC 13E3/A - Going private transaction statement (amendment)·Q3 26·11 Aug
  • … Limited since May 2023, an independent non-executive director of Trip.com (NASDAQ: TCOM: HKEX: 9961) since February 2026, an independent non-executive director and chairwoman of the audit committee of <strong>Alibaba Health Information Technology Limited</strong> (HKEX: 00241) since August 2023 and an independent non-executive director and chairwoman of the audit committee of Swire Properties Limited (HKEX: 01972) since May 2017. Ms. Wu has also served as an ind …
    MakeMyTrip LtdAlibaba Health Information Technology Limited/ADR Unsponsored ADR·EX-99.4 - 6-K - Current report (foreign private issuer)·Q2 27·7 Aug

Key Stats

Trading

Px/Chg 1D$7.05 / -9.38%
Avg Volume527.77
Beta0.64
Mkt Cap5.68B
FD Mkt Cap6.48B

Float

Shrs Out/Float806.32M / 293.23M
Short Float0.00%
Days to Cover1.00
Stock Repurchased$0.00

Current Valuation

EV13.85M
EV/EBITDA0.00
EV/Sales0.00
P/B0.32
P/S0.00
FCF Yield13.36%
ROE7.13%
ROA5.39%
Current Ratio2.71

Estimates

P/E0.00
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgSep '22Sep '23Sep '24Sep '25Oct '26
PRICE-BASED RATIOS
Price / Earnings6.56-23.4815.678.2723.708.65
Price / Sales0.440.300.310.270.960.33
Price / Book Value0.560.440.550.500.960.32
Price / Free Cash Flow16.4815.2333.566.9119.247.48
ENTERPRISE VALUE METRICS
Enterprise Value2,149.8-4,203.8-2,473.63,871.513,541.313.8
Enterprise Value / Sales0.14-0.20-0.090.140.830.00
Enterprise Value / EBITDA29.3322.35101.063.8819.340.02
Enterprise Value / EBIT17.7816.9048.034.1019.880.02

Financials

Full Financials
Millions CNY5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue12.7%20,577.626,763.027,026.630,598.333,191.5
Gross Income18%4,108.05,701.35,895.37,432.17,955.2
EBITDA—-188.1-24.5999.11,620.21,829.8
EBIT—-248.7-51.5945.41,562.61,778.2
Net Income—-265.6535.7883.51,432.41,876.0
EPS (Diluted)—-0.390.791.251.782.40
BALANCE SHEET
Cash & ST Inv-24.5%10,547.910,917.29,553.18,099.810,445.1
Total Assets4.6%19,202.020,747.619,705.321,178.423,006.9
Total Liabilities42.3%5,129.75,600.25,187.74,865.35,217.0
Total Shareholder Equity6%14,098.415,173.714,544.216,312.217,788.7
CASH FLOW
Net Operating Cash Flow48.7%424.4255.71,079.81,395.0—
Cap Ex8.2%-14.9-5.6-22.8-18.9—
Free Cash Flow49.8%409.4250.11,057.11,376.1—

Enterprise Value Bridge

Millions CNY23 Oct '26
Price (As of 23 Oct '26)6.78
Basic Shares806.32
Market Cap5,466.9
Diluted Shares809.95
Fully Diluted Shares Outstanding809.95
Fully Diluted Market Cap5,491.4
+Consolidated Debt59.5
−In-the-Money Convertible Debt—
+Capital Leases30.1
+Operating Leases—
−Cash & Equivalents-5,731.4
−Short-term Investments-4,713.7
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest1.2
+Pension Liabilities—
Enterprise Value-203.9

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Doximity, Inc.

DOCS US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US